#2 The Pill

Clonetech Internal Testing Documentation

Project: Hyperion Replication Series – Field Portable Devices

Lead Tester: Dr. Elias Voss

Classification: Restricted – Level 4

Subject: “Lila” (Designation: Test Subject 47-A)

Device Under Test: #2 Multi Pill (Batch Beta-3)

Test Log 006 – Multi Pill (Batch Beta-3)

Date: 20XX-08-XX

Time: 19:10 – 22:40

Location: Observation Chamber 3-B (post-cleaning, reinforced containment fields active, emergency sedation systems primed)

Pre-Test Briefing:

The Multi Pill is designed as an ingestible replication catalyst. Upon swallowing, the pill triggers a controlled cellular mitosis event that splits the subject’s body into two perfect, fully functional identical copies. The original consciousness is intended to remain dominant in one body while the new clone receives a temporary imprinted neural map. Duration: 90 minutes or until the pill’s active compounds are fully metabolized and exit the body naturally. Intended use: emergency duplication for high-risk operations, medical procedures, or personal assistance.

Subject 47-A (Lila) was briefed and signed the updated consent forms. She entered the chamber looking energetic, commenting that “after yesterday’s gun I’ve been thinking about this all day.” Baseline arousal markers were already mildly elevated. I administered the single Multi Pill at 19:15 under direct visual supervision. Lila swallowed it with water and licked her lips. “Tastes like cherries,” she noted.

Test Sequence 1: Initial Split (Intended Function)

At T+9 minutes post-ingestion, the splitting process began. Lila’s body emitted a soft bioluminescent glow. She gasped, doubled over slightly, then straightened as her form smoothly divided down the midline. Two perfect, identical Lilas now stood in the chamber, both breathing heavily and looking at each other with wide-eyed fascination.

“Wow… that felt incredible,” they said in unison. Physical and neurological scans confirmed 100% fidelity. Both instances passed standard coordination, memory, and cognitive tests. They high-fived, then hugged. The hug lingered. I reminded them of the test protocol.

For the first 28 minutes, behavior remained within parameters. The two Lilas performed simple tasks, answered questions alternately, and demonstrated seamless shared knowledge. The pill appeared to be functioning exactly as designed. Early data looked promising.

Test Sequence 2: Arousal Trigger & Cascade Failure

At approximately 19:52, one Lila brushed her hand along the other’s arm. Then her waist. Then lower. Within seconds both were engaged in heavy mutual exploration, citing “we need to test sensory continuity.”

Arousal spiked across the board. At T+41 minutes, the original Lila (still identifiable by a faint marker dot on her shoulder) shuddered violently and split again — producing a third perfect copy mid-intimacy. The new clone emerged already highly stimulated and immediately joined the others.

Critical Failure Point: The Multi Pill’s replication trigger is not limited to the original host. Every clone carrying active metabolites can also split when sufficiently aroused. This was not anticipated in the design.

What followed was an exponential replication event.

20:05 → 5 Lilas

20:18 → 14 Lilas

20:37 → 41 Lilas (estimated — visual confirmation became difficult due to density)

The chamber filled with synchronized, overlapping sounds of pleasure. Clones were splitting faster as the group activity intensified. Some new instances were created while still partially merged with their “parent,” creating brief, surreal multi-body configurations before fully separating.

I activated the containment fields and issued urgent commands over the intercom: “Lila Prime, you must stop all physical stimulation immediately!” Multiple voices answered back, laughing and moaning, “But Doctor… it feels better every time we split!”

Emergency Containment & Resolution

At 21:04, with biomass approaching structural risk and the replication rate accelerating, I declared a Code Black. The observation team deployed aerosolized fast-acting sedative through the chamber vents. It took nearly seven minutes for the gas to affect all instances due to their increasing numbers and heightened metabolic states.

One by one the Lilas collapsed where they stood, bodies entwined. The splitting finally ceased. Medical teams in hazmat suits entered at 21:42 to extract the original subject.

Pill Termination:

Per design, the replication effect ended naturally as the active compounds exited the body. Full metabolic clearance was confirmed via bloodwork at 22:30. All clones dissolved harmlessly once the pill’s influence ended. The original Lila was unconscious for another 45 minutes and woke up disoriented but physically intact.

Her first words upon regaining consciousness: “That was the best multiplication I’ve ever had… When’s the next dose?”

Post-Test Analysis

Success Rating: Partial. The initial splitting mechanism works flawlessly and produces high-fidelity clones. However, the Multi Pill is fundamentally unsafe under real-world conditions, especially with high-libido subjects.

Critical Observations:

Arousal is a powerful and uncontrollable replication catalyst.

Clones inherit full splitting capability, leading to runaway exponential growth.

Sedation was the only effective way to regain control.

Natural excretion of the pill reliably terminates the effect.

Recommendations for Redesign / Upgrades:

Original-Only Splitting: Restrict replication trigger exclusively to the body that originally ingested the pill. Clones must be non-replicative.

Single Clone Limit: Hard-cap at exactly one additional clone per pill, with no further divisions possible.

Arousal Inhibitor: Integrate strong libido-suppressing compounds that activate automatically upon splitting.

Faster Metabolic Exit: Shorten active window or add voluntary expulsion trigger (e.g., induced vomiting or accelerated digestion) for emergency shutdown.

Neural Lock: Prevent clones from experiencing full sensory feedback from the collective to avoid group arousal escalation.

Current Status: Device FAILED pending major updates. Mass production is NOT recommended. Further testing on Subject 47-A is suspended until V2 is ready.

Personal Note:

Today’s test was chaos on a scale that makes the Cloning Gun incident look tame. Watching dozens of identical Lilas multiplying in real time while completely lost in pleasure was both scientifically fascinating and deeply unsettling. The sedative worked, but the cleanup crew is not happy with me.

I have requested stronger containment protocols and possibly a second test subject with lower libido for baseline comparisons. Lila has already asked if she can keep a few “souvenir pills” for personal use. Request denied.

End of Test Log 006.